KG
GILD icon

Kilter Group’s Gilead Sciences GILD Stock Holding History

Kilter Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.5K Buy
360
+34
+10% +$4.48K 0.02% 151
2026
Q1 		$45.4K Buy
326
+7
+2% +$980 0.02% 131
2025
Q4 		$39.2K Buy
319
+20
+7% +$2.43K 0.02% 139
2025
Q3 		$33.2K Buy
299
+3
+1% +$341 0.02% 143
2025
Q2 		$32.8K Buy
+296
New +$31.5K 0.01% 128

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kilter Group's GILD Position: Q2 2026 in Review

Kilter Group increased its Gilead Sciences (GILD) stake by 10% in Q2 2026, buying an estimated $4.48K and bringing the position to 360 shares worth $45.5K. The position accounts for 0.02% of the portfolio, ranked #151.

Kilter Group first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Kilter Group held 360 shares of Gilead Sciences worth $45.5K as of Q2 2026.
  • Kilter Group bought 34 Gilead Sciences shares in Q2 2026, an estimated $4.48K.
  • Gilead Sciences made up 0.02% of Kilter Group's portfolio in Q2 2026, its #151 holding.
  • Kilter Group first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.